Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors
- 1 November 2004
- journal article
- clinical trial
- Published by Elsevier
- Vol. 94 (9) , 1140-1146
- https://doi.org/10.1016/j.amjcard.2004.07.080
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Rosuvastatin — warfarin drug interactionThe Lancet, 2004
- Case Report: Drug-Induced Rhabdomyolysis after Concomitant Use of Clarithromycin, Atorvastatin, and Lopinavir/Ritonavir in a Patient with HIVAIDS Patient Care and STDs, 2003
- Statin-Associated MyopathyJAMA, 2003
- Rhabdomyolysis from Cytochrome P-450 Interaction of Ketoconazole and Simvastatin in Prostate CancerJournal of Urology, 2003
- Safety and Tolerability of Pravastatin in Long-Term Clinical TrialsCirculation, 2002
- Cerivastatin and Reports of Fatal RhabdomyolysisNew England Journal of Medicine, 2002
- Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokineticsFundamental & Clinical Pharmacology, 1999
- Coadministration of Itraconazole With Hypolipidemic Agents May Induce Rhabdomyolysis in Healthy IndividualsArchives of Dermatology, 1996
- Drug-interaction-induced rhabdomyolysisNephrology Dialysis Transplantation, 1996
- Rhabdomyolysis from the Coadministration of Lovastatin and the Antifungal Agent ItraconazoleNew England Journal of Medicine, 1995